A joint Call to Action 2.0, released by WHO and partners, calls for urgent actions by governments and donors to step up momentum to rapidly enhance coverage of TB preventive treatment for those in need.

The World Health Organization releases new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB.

Celebrating TB heroes during the COVID-19 pandemic.

The 2021 Political Declaration on HIV and AIDS, adopted by world leaders, commits to end HIV/AIDS and TB by 2030 and reverse the progress lost due to the COVID-19 pandemic.

The Stop TB Partnership and USAID launch a new report assessing the governance of National TB Programmes in 22 countries which together account for over 70% of the global TB burden.

The tools are meant to help build awareness of TB in communities, share information on the latest scientific and policy developments, and inform activism to address barriers to TB diagnosis, treatment, and care.

The Stop TB Partnership launches the first of two online consultations to inform the development of the new Global Plan to End TB for the period 2023 to 2030.

The Time for $5 Coalition calls out Cepheid for not including price reductions of Xpert tests in their updated GeneXpert pricing packages for low- and middle-income countries.

A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.

TAG and AfroCAB are inviting applications from treatment activists and community leaders for a new cross-disease long-acting technologies community advisory board. The deadline to apply is 21 May 2021.